Sterling Capital Management
IMVT icon

Sterling Capital Management’s Immunovant IMVT Stock Holding History

Sterling Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96.9K Buy
2,868
+2,568
+856% +$101K ﹤0.01% 1448
2026
Q2 		$11.6K Sell
300
-229
-43% -$6.98K ﹤0.01% 2144
2026
Q1 		$13.1K Buy
529
+75
+17% +$1.94K ﹤0.01% 2230
2025
Q4 		$11.5K Buy
454
+288
+173% +$6.42K ﹤0.01% 2535
2025
Q3 		$2.68K Buy
166
+1
+0.6% +$16 ﹤0.01% 2933
2025
Q2 		$2.64K Buy
165
+104
+170% +$1.57K ﹤0.01% 2839
2025
Q1 		$1.04K Buy
61
+4
+7% +$84 ﹤0.01% 2798
2024
Q4 		$1.41K Sell
57
-1
-2% -$28 ﹤0.01% 2869
2024
Q3 		$1.65K Buy
+58
New +$1.71K ﹤0.01% 2272

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Inspire Investing
Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management's IMVT Position: Q3 2026 in Review

Sterling Capital Management increased its Immunovant (IMVT) stake by 856% in Q3 2026, buying an estimated $101K and bringing the position to 2,868 shares worth $96.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.

Sterling Capital Management first reported a position in IMVT in Q3 2024 and has held it in 9 quarters since. 23 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Sterling Capital Management held 2,868 shares of Immunovant worth $96.9K as of Q3 2026.
  • Sterling Capital Management bought 2,568 Immunovant shares in Q3 2026, an estimated $101K.
  • Immunovant made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1448 holding.
  • Sterling Capital Management first reported a position in Immunovant in Q3 2024 and has held it in 9 quarters since.
  • 23 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.